DYRK1A

Chr 21AD

dual specificity tyrosine phosphorylation regulated kinase 1A

Also known as: DYRK, DYRK1, HP86, MNB, MNBH, MRD7

This gene encodes a dual-specificity kinase that catalyzes autophosphorylation on serine/threonine and tyrosine residues and regulates cell proliferation and brain development. Mutations cause intellectual developmental disorder, autosomal dominant 7, predominantly through loss-of-function mechanisms. The gene shows extremely high constraint against loss-of-function variants (pLI 1.0, LOEUF 0.21), consistent with haploinsufficiency as the primary pathogenic mechanism.

GeneReviewsOMIMResearchSummary from RefSeq, OMIM, UniProt, Mechanism
LOFmechanismADLOEUF 0.211 OMIM phenotype
Clinical SummaryDYRK1A
🧬
Gene-Disease Validity (ClinGen)
complex neurodevelopmental disorder · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
21 unique Pathogenic / Likely Pathogenic· 22 VUS of 100 total submissions
💊
Clinical Trials
1 active or recruiting trial — potential therapeutic options may be available
📖
GeneReview available — DYRK1A
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint
0.21LOEUF
pLI 1.000
Z-score 5.11
OE 0.08 (0.040.21)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint
3.34Z-score
OE missense 0.55 (0.500.61)
246 obs / 444.4 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios
LoF OE0.08 (0.040.21)
00.351.4
Missense OE0.55 (0.500.61)
00.61.4
Synonymous OE1.15
01.21.6
LoF obs/exp: 3 / 36.2Missense obs/exp: 246 / 444.4Syn Z: -1.48
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveDYRK1A-related intellectual developmental disorderLOFAD
DN
0.2897th %ile
GOF
0.2895th %ile
LOF
0.84top 5%

The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).

LOFprediction above median · 1 literature citation · 86% of P/LP variants are LoF · LOEUF 0.21

Literature Evidence

LOFImpaired development of neocortical circuits contributes to the neurological alterations in DYRK1A haploinsufficiency syndrome.PMID:30831192

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

100 submitted variants in ClinVar

Classification Summary

Pathogenic14
Likely Pathogenic7
VUS22
Likely Benign51
Benign2
Conflicting4
14
Pathogenic
7
Likely Pathogenic
22
VUS
51
Likely Benign
2
Benign
4
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
13
0
1
0
14
Likely Pathogenic
5
2
0
0
7
VUS
0
19
2
1
22
Likely Benign
0
4
14
33
51
Benign
0
1
0
1
2
Conflicting
4
Total18261735100

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

DYRK1A · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold
Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Top 5 results · since 2015Search PubMed ↗